Panel: HTA/Payer Commercial negotiations – how and when to conduct these
Tuesday, November 3, 2020 2:35 PM to 3:40 PM · 1 hr. 5 min. (Africa/Abidjan)
Access & Pricing
Information
- Will COVID-19 slowed down the access to orphan drugs?
- How can orphan drug manufacturers demonstrate value and improve access to drugs?
- Commercial negotiations – how and when to conduct these
- What is necessary to align regulatory and HTA activities on OMPs